Dr. Robin Smith discusses NeoStem and its platform therapies with Pimm Fox, anchor of Bloomberg Radio's Taking Stock.
© 2014 Bloomberg L.P. All rights reserved. Used with permission.
Dr. Robin Smith shares tip and insight with Investors Business Daily shares about increasing a company's value through M&A.
Dr. Robin Smith spoke with Drug Discovery News about NeoStem's new Targeted Immunotherapy Program and its expected launch of a Phase 3 trial for metastatic melanoma.
NeoStem Profile by BTV
Business Television (BTV) visited NeoStem to speak with Dr. Robin Smith, Chairman and CEO, and Dr. Douglas Losordo,Chief Medical Officer,